This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_OTHER_NOS_EXALLC for full statistics.
Carcinoma in situ of other and unspecified sites
CD2_INSITU_OTHER_NOS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
104
Check minimum number of events None
104
Include endpoints
760
Remove individuals based on genotype QC
734
CD2_INSITU_OTHER_NOS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D00-D09
Name in latin
Carcinoma in situ locis aliis sive non specificatis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified sites
based on the number of shared cases.
Broader endpoints:
- Carcinoma in situ of other and unspecified sites (controls excluding all cancers)
- In situ neoplasms (controls excluding all cancers)
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 734 | 144 | 590 |
| Unadjusted prevalence (%) | 0.19 | 0.07 | 0.35 |
| Mean age at first event (years) | 70.00 | 65.83 | 71.02 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_OTHER_NOS – Carcinoma in situ of other and unspecified sites
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Carcinoma in situ of other and unspecified sites
↥Endpoint not on priority list, no data to show.